Lainka Elke, Neudorf Ulrich, Lohse Peter, Timmann Christian, Stojanov Silvia, Huss Kristina, von Kries Rudiger, Niehues Tim
Department of Paediatric Rheumatology, Children's Hospital, University Duisburg-Essen, Essen, Germany.
Rheumatology (Oxford). 2009 Aug;48(8):987-91. doi: 10.1093/rheumatology/kep140. Epub 2009 Jun 18.
TNF receptor 1-associated periodic syndrome (TRAPS) is a rare disease belonging to the heterogeneous group of hereditary periodic fever (HPF) syndromes. By their monogenic origins, the HPF syndromes are clearly differentiated from other periodic inflammatory episodes occurring in autoimmune, neoplastic and infectious diseases. We aim to determine the incidence of TRAPS and the spectrum of mutations in the TNFRSF1A gene, and to give a brief survey of clinical signs.
A prospective surveillance of children with TRAPS was conducted in Germany during a time period of 3 years (2003-06). Monthly inquiries were sent to 370 children's hospitals by the German Pediatric Surveillance Unit (Clinic-ESPED, n1) and to 23 laboratories (Laboratory-ESPED, n2). Inclusion criteria were TNFRSF1A mutation-positive patients < or =16 years of age, more than three self-limiting episodes of fever >38.5 degrees C, and increased inflammation markers. Clinical, epidemiological and genetic data were evaluated via questionnaires.
Of the 23 cases included, 19 were identical in 20 clinical and 22 laboratory reports. The incidence of TRAPS in German children was estimated to be approximately 5.6 per 10(7) person-years. In 20 TRAPS patients of the Clinic-ESPED, median age of onset and duration of fever periods were 6 (range 1-16) years and 6.3 (range 2-24) days, respectively. Main symptoms were arthralgia, abdominal pain, lymphadenopathy, headache and skin involvement. The R92Q substitution was found in 19 (83%) of 23 cases.
The incidence of TRAPS is low and corresponds to 6-10 newly diagnosed patients < or =16 years per year in Germany.
肿瘤坏死因子受体1相关周期性综合征(TRAPS)是一种罕见疾病,属于遗传性周期性发热(HPF)综合征这一异质性疾病组。由于其单基因起源,HPF综合征与自身免疫性、肿瘤性和感染性疾病中发生的其他周期性炎症发作明显不同。我们旨在确定TRAPS的发病率以及肿瘤坏死因子受体超家族成员1A(TNFRSF1A)基因的突变谱,并简要概述临床体征。
在德国对TRAPS患儿进行了为期3年(2003 - 2006年)的前瞻性监测。德国儿科监测单位(临床-ESPED,n1)每月向370家儿童医院以及23家实验室(实验室-ESPED,n2)发送询问函。纳入标准为TNFRSF1A突变阳性、年龄≤16岁、有超过三次体温>38.5℃的自限性发热发作且炎症标志物升高的患者。通过问卷对临床、流行病学和基因数据进行评估。
在纳入的23例病例中,20份临床报告和22份实验室报告中的19例情况相同。德国儿童TRAPS的发病率估计约为每10^7人年5.6例。在临床-ESPED的20例TRAPS患者中,发病年龄中位数和发热期持续时间分别为6(范围1 - 16)岁和6.3(范围2 - 24)天。主要症状为关节痛、腹痛、淋巴结病、头痛和皮肤受累。在23例病例中的19例(83%)发现了R92Q替代突变。
TRAPS的发病率较低,在德国每年约有6 - 10名新诊断的≤16岁患者。